Exercise of Options
July 08 2009 - 11:16AM
UK Regulatory
TIDMAOI
RNS Number : 3679V
AOI Medical, Inc.
08 July 2009
Press Information
AOI Medical, Inc.
Exercise of Options
London, UK, 8 July 2009 - AOI Medical, Inc. (the "Company" or "AOI") (AIM: AOI)
announces that following the exercise of options on 2 July 2009, the Company has
made application for 100,000 common shares of US$0.0001 each to be admitted to
AIM. The shares are expected to be admitted to trading on 14 July 2009.
Enquiries:
+------------------------------------------------+----------------------------------------+
| AOI Medical, Inc. | Tel: +1 407 770 1800 |
+------------------------------------------------+----------------------------------------+
| William J. Christy, CEO | |
+------------------------------------------------+----------------------------------------+
| | |
+------------------------------------------------+----------------------------------------+
| Numis Securities Limited | Tel: +44 (0) 20 7260 1000 |
+------------------------------------------------+----------------------------------------+
| Nominated Adviser: Michael Meade / Brent Nabbs | |
+------------------------------------------------+----------------------------------------+
| Corporate Broking: David Poutney | |
+------------------------------------------------+----------------------------------------+
| | |
+------------------------------------------------+----------------------------------------+
| The Investor Relations Group | |
+------------------------------------------------+----------------------------------------+
| Erika Moran/Tom Caden | Tel: +1 212 825 3210 |
+------------------------------------------------+----------------------------------------+
| Public Relations: Susan Morgenbesser | |
+------------------------------------------------+----------------------------------------+
Background to AOI Medical, Inc.
AOI is a medical device company focusing on the development and
commercialisation of innovative orthopaedic medical devices for the spine and
trauma markets. It is progressing the development of three separate technology
platforms: Ascendx(TM) VCF Reduction System, BAMF
Trauma and Cervical Plate. Further information can be found at www.aoimedical.n
t
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBLGDRDBGGGCI
Aoi (Regs) (LSE:AOI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Aoi (Regs) (LSE:AOI)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Aoi (Regs) (London Stock Exchange): 0 recent articles
More Aoi (Regs) News Articles